Best Sermorelin Providers in 2026 — Ranked & Reviewed
Body composition, recovery and sleep are what sermorelin, a growth-hormone-releasing hormone analog, is prescribed for. Where you buy matters, because it is prescription-only in the US and the market is thick with gray-market "research peptide" sellers operating outside any doctor-patient relationship. Each provider below is a telehealth clinic we score independently, and each prescribes through a licensed clinician. The order here follows that score. A sermorelin price appears in the table wherever a clinic publishes one, which most do not — they quote after your consultation. If cost is the thing you are optimizing for, /best/cheapest-sermorelin ranks the same clinics by price instead.
Lowest verified price: $89/mo107 providers compared
New to Sermorelin? Read our full Sermorelin guide — evidence, dosing, safety and side effects.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
107 sermorelin providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
knowing which pharmacy fills the vial — it names RedRock Pharmacy
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin - Nationwide Coverage
semaglutide at $99/month, 48% under the register median
From /mo$99Coverage50 statesMedicationsNAD+Sermorelin - Best Budget
starting below a standard dose, with microdose tiers
From /mo$89Coverage50 statesMedicationsGlutathioneNAD+Sermorelin bloodwork inside the $99/month rather than billed on top
From /moCheck pricingCoverage36 statesMedicationsBPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141retatrutideSermorelinTB-500Tesamorelinsemaglutide at $105/month, 44% under the register median
From /mo$195Coverage42 statesMedicationsNAD+Sermorelinmoving between compounded and brand without changing seller
From /moCheck pricingCoverage50 statesMedicationsNAD+Sermorelinsemaglutide at $99/month, 48% under the register median
From /mo$99Coverage49 statesMedicationsNAD+Sermorelinknowing which pharmacy fills the vial — it names Beaker Pharmacy
From /mo$196Coverage47 statesMedicationsGlutathioneNAD+Sermorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick knowing which pharmacy fills the vial — it names RedRock Pharmacy | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
Nationwide Coverage semaglutide at $99/month, 48% under the register median | $99 | NAD+Sermorelin | 50 states | Visit → | |
Best Budget starting below a standard dose, with microdose tiers | $89 | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
 bloodwork inside the $99/month rather than billed on top | Check pricing | BPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141retatrutideSermorelinTB-500Tesamorelin | 36 states | Visit → | |
 semaglutide at $105/month, 44% under the register median | $195 | NAD+Sermorelin | 42 states | Visit → | |
 moving between compounded and brand without changing seller | Check pricing | NAD+Sermorelin | 50 states | Visit → | |
 semaglutide at $99/month, 48% under the register median | $99 | NAD+Sermorelin | 49 states | Visit → | |
 knowing which pharmacy fills the vial — it names Beaker Pharmacy | $196 | GlutathioneNAD+Sermorelin | 47 states | Visit → |
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Detailed Reviews
About the prices below: every dollar figure inside these provider summaries belongs to that clinic’s GLP‑1 weight-loss program. None is a Sermorelin price. For Sermorelin itself, read the figure next to each clinic in the comparison table above, taken from the clinic’s own product page. A reading of “Check pricing” means the clinic does prescribe Sermorelin and publishes nothing for it, so you are quoted after your consultation.
Embody
Best for: knowing which pharmacy fills the vial — it names RedRock Pharmacy
Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.
Score Breakdown
Pros
- ✓Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $129 a month, 52% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓Names 4 dispensing pharmacies, which most sellers in this register do not do
- ✓No FDA warning letter matched this operator when we searched our enforcement register
- ✓Both oral and injectable options are on record, so the format is a choice rather than a condition
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
CoreAge Rx
Verified partnerBest for: semaglutide at $99/month, 48% under the register median
Shipping is free, 2-day, and reaches all 50 states. CoreAge Rx sells LegitScript-verified compounded semaglutide plus tirzepatide, with licensed physicians behind it and 24/7 support. Its own claim: nobody in the compounded GLP-1 space prices more competitively.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $149 a month, 44% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
bmiMD
Best for: starting below a standard dose, with microdose tiers
bmiMD is a medical weight loss clinic that prescribes GLP-1 medications through telehealth.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $139 a month, 48% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Pepti
Best for: bloodwork inside the $99/month rather than billed on top
One flat charge holds regardless of dose: $99 a month for injectable semaglutide, $199 for tirzepatide, each figure covering shipping, refill management, baseline labs, physician review and the drug itself. Registered in Delaware, the platform reaches 36 states with doctor-prescribed compounded peptides and GLP-1s, and its catalog passes 120 products spanning skin, cognitive, recovery, TRT and hormone, and weight-loss categories, bloodwork at home included. Insurance is not billed. Pepti prescribes nothing itself; it is the platform.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- ✓The monthly figure covers medication, consult, shipping, labs
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗Coverage is published for 36 states only, so this may not reach you
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
PeterMD
Best for: semaglutide at $105/month, 44% under the register median
Monthly pricing is published and no insurance is required. PeterMD sells compounded GLP-1 weight loss medications to men: tirzepatide and semaglutide, often with B12 added. Anti-aging treatments, sexual health, peptide therapy and TRT round out the telehealth menu.
Score Breakdown
Pros
- ✓Semaglutide at $105 a month, 44% below the $189 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for 42 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What decides a sermorelin purchase
Sermorelin is an analog of growth-hormone-releasing hormone. Geref, the brand that once carried an FDA approval for pediatric GH deficiency, is discontinued. Everything on sale today is therefore compounded, and all of it requires a prescription. The prescriber and the pharmacy are therefore most of the decision.
What to check
- A licensed prescriber, and a pharmacy named. Clinics differ from one another far less than they differ from gray-market sellers. Two checks separate the groups: a licensed clinician reading the intake, and a 503A or 503B pharmacy named as the compounder of the vial.
- IGF-1 at baseline and again later. The mechanism is a rise in the patient's own growth hormone, and IGF-1 is the marker showing whether it happened. Drawn before starting and again after, it gives a clinic something to adjust against. Without those numbers, dose changes are guesses.
- Route sets the price. This is sold as an injection, as a sublingual tablet or troche, and as a nasal spray. Monthly cost tends to be lowest on the oral and sublingual forms. Two quotes only compare once the route matches, so settle that first.
Red flags
- Vials sold with no prescriber involved. A vial marked 'not for human consumption' and sold 'for research use only' sits outside the drug approval system, where identity, purity and sterility are nobody's stated responsibility. In the US, every peptide on this page needs a prescription. Where no licensed clinician writes one, the product is not the one described here.
- The 503A or 503B pharmacy is never named. No finished product for these peptides carries FDA approval, which leaves compounding as the only lawful route to a dose. Plenty of clinics name the pharmacy behind the vial. Where a clinic does not, the supply chain ends at its own claim.
- 'FDA-approved' attached to a compounded peptide. Compounding does not bring FDA approval with it, and a seller saying otherwise has committed a marketing violation rather than a slip of wording. A few of these molecules did hold an approval once, under a discontinued brand and for a separate indication. That history says nothing about the compounded vial on sale now.
- Results promised with no trial behind them. For most molecules in this category the evidence is mechanistic or early phase; randomized outcome trials are rare. A clinic promising a defined outcome for fat loss, for muscle, or for anti-aging has moved past what the literature carries. Our evidence review for each molecule sets out what exists.
- IGF-1 never drawn on a hormone-axis peptide. Raising IGF-1 is what a growth-hormone secretagogue is for, and it is also the number that shows when a dose has gone too far. A clinic measuring it at neither baseline nor follow-up has no way to tell those two states apart.
Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- 503A pharmacy · Pharmacy and drug forms
- 503A vs 503B (pharmacy compounding) · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.